Field Trip has appointed a leader in holistic and integrative medicine to its Medical Advisory Board.
Field Trip has appointed a leader in holistic and integrative medicine to its Medical Advisory Board.
After a series of significant corporate appointments, Mind Cure is poised to advance its operations.
Numinus commences psilocybin cultivation as part of its "ecosystem approach" to psychedelic drug therapy.
Mr. Bier is a communications and strategy expert who has played a key role in building brands
This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
The mental healthcare industry is ripe for innovation. And companies like Mind Cure (CSE: MCUR), which recently completed its IPO, are set to lead the way.
Mydecine's new patent application may lead to a way to derive the medicinal benefits of psilocybin at lower doses.
Mind Cure's latest addition to its Scientific Advisory Board is a noted expert in psychedelic medicine, published researcher, and professor of pharmacology.
Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Noted psychedelic drug expert, Hamilton Morris, is the latest addition to Mind Cure's advisory board.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now